Disease Domain | Count |
---|---|
Nervous System Diseases | 1 |
Immune System Diseases | 1 |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 1 |
Top 5 Target | Count |
---|---|
GABA receptor(Gamma-aminobutyric acid (GABA) receptors) | 1 |
Target |
Mechanism GABA receptor agonists |
Active Org. |
Originator Org.- |
Active Indication |
Inactive Indication- |
Drug Highest PhaseClinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date01 Aug 2026 |
Sponsor / Collaborator |
Start Date01 Aug 2025 |
Sponsor / Collaborator |
Start Date01 May 2025 |
Sponsor / Collaborator ![]() [+3] |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Beta-Alanine ( GABA receptor ) | Multiple Sclerosis More | Clinical |
MAG-283 ( MMPs ) | Corneal Ulcer More | Pending |
MAG-133 ( MMPs ) | Prostatic Cancer More | Pending |